Vajiramala R Dharmasena, MD
Obstetrics/Gynecology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Dharmasena’s office at (209) 476-2000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A62475 · Current
Licensed to practise in California · since 1997 · expires 2027-03-31 · University of Southern California Keck School of Medicine. Board flags: Arbitration Award.
Public record actions
| 2000-03-15 | Arbitration award | $40,000 · Hon. diane wayne · N/a |
Medicaid work
$185 in 2024
Medicaid paid $185 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit | 12 | $185 |
| 2024 | 12 | 1 | 12 | $185 |
Drugs they prescribed that Part D paid
$34,207
Pharmacies billed $34,207 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 243) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
208 generic and 35 brand-name prescriptions · $34,207 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estring | 17 | $10,232 | $602 |
| Estradiol | 55 | $2,365 | $43 |
| Yuvafem | 13 | $1,818 | $140 |
| Trospium Chloride | 30 | $1,294 | $43 |
| Clobetasol Propionate | 24 | $418 | $17 |
See all 8 drugs
| Estring | 17 | $10,232 | $602 |
| Estradiol | 55 | $2,365 | $43 |
| Yuvafem | 13 | $1,818 | $140 |
| Trospium Chloride | 30 | $1,294 | $43 |
| Clobetasol Propionate | 24 | $418 | $17 |
| Oxybutynin Chloride Er | 11 | $237 | $22 |
| Betamethasone Valerate | 11 | $207 | $19 |
| Hydrocortisone | 11 | $134 | $12 |
Year by year
| 2024 | 243 | 106 | 0% (0) | 14% | $34,207 |
| 2023 | 222 | 105 | 0% (0) | 17% | $35,563 |
| 2022 | 158 | 85 | None | 18% | $20,748 |
| 2021 | 96 | 45 | 0% (0) | 16% | $12,159 |
| 2020 | 53 | 29 | 0% (0) | 23% | $8,470 |
| 2019 | 82 | 35 | 0% (0) | 18% | $27,765 |
| 2018 | 38 | 16 | 0% (0) | 39% | $11,754 |
| 2017 | 45 | 23 | 0% (0) | 27% | $6,764 |
| 2016 | 33 | 15 | 0% (0) | None | $4,829 |
| 2015 | 40 | 16 | None | 43% | $5,945 |
| 2014 | 51 | 21 | None | 47% | $6,871 |
| 2013 | 48 | 19 | None | 44% | $6,181 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Myrbetriq | 13 | $18,148 | $1,396 |
| Estring | 15 | $8,823 | $588 |
| Estradiol | 51 | $2,158 | $42 |
| Yuvafem | 12 | $1,473 | $123 |
| Trospium Chloride | 16 | $828 | $52 |
| Oxybutynin Chloride Er | 14 | $215 | $15 |
| Clobetasol Propionate | 13 | $160 | $12 |
| Fluconazole | 15 | $100 | $7 |
2022: 4 drugs
| Estring | 15 | $8,445 | $563 |
| Estradiol | 49 | $2,107 | $43 |
| Oxybutynin Chloride Er | 15 | $535 | $36 |
| Fluconazole | 14 | $105 | $8 |
2021: 2 drugs
| Estradiol | 36 | $1,740 | $48 |
| Fluconazole | 14 | $104 | $7 |
2020: 1 drug
| Estradiol | 19 | $1,437 | $76 |
2019: 2 drugs
| Lidocaine | 20 | $3,254 | $163 |
| Estradiol | 14 | $593 | $42 |
Money from drug and device companies
$208 in 2024
A payment is not proof that care is biased.
| Biogen | None | $121 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $87 | 1 payment
|
See all 2 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2024-05-30 | Xifaxan | $87 |
| Biogen | Meals · 2024-04-02 | None | $121 |
Professional record
- NPI
- 1003968801
- Licence
- CA A62475California A62475: Current · expires 2027-03-31
- Trained
- University of Southern California Keck School of Medicine, 1995
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A624750
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2007-01-18
- NPI last updated
- 2021-12-06
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.